UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 193

Sortiert nach

Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study)

Journal of clinical oncology, 2023-02, Vol.41 (5), p.1069-1078

2023

Volltextzugriff (PDF)

A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer

Breast cancer research and treatment, 2020-04, Vol.180 (3), p.715-724

2020

Volltextzugriff (PDF)

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)

Breast cancer (Tokyo, Japan), 2018-07, Vol.25 (4), p.438-446

2018

Volltextzugriff (PDF)

Radiofrequency ablation of early breast cancer followed by delayed surgical resection – A promising alternative to breast-conserving surgery

Breast (Edinburgh), 2011-10, Vol.20 (5), p.431-436

2011

Volltextzugriff (PDF)

The efficacy and safety of FSK0808, filgrastim biosimilar: a multicenter, non-randomized study in Japanese patients with breast cancer

Japanese journal of clinical oncology, 2013-09, Vol.43 (9), p.865-873

2013

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer: NACED-Randomized Multicenter Phase II Trial

Acta medica Okayama, 2015-10, Vol.69 (5), p.291-299

2015

Volltextzugriff (PDF)

Stereotactic directional vacuum-assisted breast biopsy using lateral approach

Breast cancer (Tokyo, Japan), 2010-10, Vol.17 (4), p.286-289

2010

Volltextzugriff (PDF)

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2017-12, Vol.18 (12), p.1688-1700

2017

Volltextzugriff (PDF)

Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial

Journal of clinical oncology, 2023-06, Vol.41 (18), p.3329-3338

2023

Volltextzugriff (PDF)

A randomized study comparing docetaxel/cyclophosphamide

Breast cancer research and treatment, 2020-04, Vol.180 (3), p.715

2020

Volltextzugriff (PDF)

A randomized study comparing docetaxel/cyclophosphamide followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer

Breast cancer research and treatment, 2020-04, Vol.180 (3), p.715

2020

Volltextzugriff (PDF)

Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers

Breast cancer research and treatment, 2014-01, Vol.143 (2), p.403-409

2014

Volltextzugriff (PDF)

Health-related quality of life and psychological distress during neoadjuvant endocrine therapy with letrozole to determine endocrine responsiveness in postmenopausal breast cancer

Breast cancer research and treatment, 2014-05, Vol.145 (1), p.155-164

2014

Volltextzugriff (PDF)

Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phase II trial

Oncology reports, 2013-05, Vol.29 (5), p.1707-1713

2013

Volltextzugriff (PDF)

Neoadjuvant chemotherapy with or without the concurrent hormone therapy that has downregulated estrogen level in estrogen receptor positive breast cancer: NACED randomized multicenter phase II trial

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e11501-e11501

2015

Volltextzugriff (PDF)

Safety and efficacy of gemcitabine and trastuzumab in HER2-directed therapy pretreated patients with HER2-positive metastatic breast cancer: SBP-01 study

Journal of clinical oncology, 2015-10, Vol.33 (28_suppl), p.142-142

2015

Volltextzugriff (PDF)

The utility of bi-weekly eribulin therapy for metastatic breast cancer: A Japanese multicenter phase II study (JUST-STUDY)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.1026-1026

2015

Volltextzugriff (PDF)

Analysis of health-related quality of life during neoadjuvant endocrine therapy with letrozole in postmenopausal breast cancer patients: N-SAS BC06 trial

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.6588-6588

2013

Volltextzugriff (PDF)

Phase II study of neoadjuvant chemotherapy with a metronomic regimen of paclitaxel + cyclophosphamide + capecitabine followed by 5-fluorouracil + epirubicin + cyclophosphamide in operable triple-negative breast cancer (JBCRG-13 study)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.1048-1048

2013

Volltextzugriff (PDF)

PO80 NEUTROPENIA MAY BE A PREDICTION MARKER OF THERAPEUTIC EFFECT IN METASTATIC BREAST CANCER PATIENTS TREATED WITH ERIBULIN

Breast (Edinburgh), 2013-11, Vol.22, p.S47-S47

2013

Volltextzugriff (PDF)

PO46 PULMONARY RESECTION FOR LUNG OLIGOMETASTATIC DISEASE IN METASTATIC BREAST CANCER

Breast (Edinburgh), 2013-11, Vol.22, p.S35-S35

2013

Volltextzugriff (PDF)

PO45 SURGICAL RESECTION OF THE PRIMARY TUMOR MAY IMPROVE SURVIVAL IN PATIENTS WITH STAGE IV BREAST CANCER

Breast (Edinburgh), 2013-11, Vol.22, p.S35-S35

2013

Volltextzugriff (PDF)

A multicenter phase II trial of the LH-RH analogue and an aromatase inhibitor combination in premenopausal patients with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: JMTO BC08-01

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.588-588

2012

Volltextzugriff (PDF)

Clinical Study of Roux Stasis Syndrome after Distal Gastrectomy

The Japanese Journal of Gastroenterological Surgery, 2008, Vol.41(8), pp.1551-1556

2008

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(176)

Publikationsform

Sprache

Englisch
(159)
Japanisch
(76)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Smartphone Psychotherapy Reduces Fear of Cancer Recurrence Among Breast Cancer Survivors: A Fully Decentralized Randomized Controlled Clinical Trial (J-SUPPORT 1703 Study)

A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)

Radiofrequency ablation of early breast cancer followed by delayed surgical resection – A promising alternative to breast-conserving surgery

The efficacy and safety of FSK0808, filgrastim biosimilar: a multicenter, non-randomized study in Japanese patients with breast cancer

Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer: NACED-Randomized Multicenter Phase II Trial

Stereotactic directional vacuum-assisted breast biopsy using lateral approach

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial

A randomized study comparing docetaxel/cyclophosphamide

A randomized study comparing docetaxel/cyclophosphamide followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer

Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers

Optimizing smartphone psychotherapy for depressive symptoms in patients with cancer: Multiphase optimization strategy using a decentralized multicenter randomized clinical trial (J‐SUPPORT 2001 Study)

Health-related quality of life and psychological distress during neoadjuvant endocrine therapy with letrozole to determine endocrine responsiveness in postmenopausal breast cancer

Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phase II trial

Neoadjuvant chemotherapy with or without the concurrent hormone therapy that has downregulated estrogen level in estrogen receptor positive breast cancer: NACED randomized multicenter phase II trial

Safety and efficacy of gemcitabine and trastuzumab in HER2-directed therapy pretreated patients with HER2-positive metastatic breast cancer: SBP-01 study

The utility of bi-weekly eribulin therapy for metastatic breast cancer: A Japanese multicenter phase II study (JUST-STUDY)

Analysis of health-related quality of life during neoadjuvant endocrine therapy with letrozole in postmenopausal breast cancer patients: N-SAS BC06 trial

Phase II study of neoadjuvant chemotherapy with a metronomic regimen of paclitaxel + cyclophosphamide + capecitabine followed by 5-fluorouracil + epirubicin + cyclophosphamide in operable triple-negative breast cancer (JBCRG-13 study)

PO80 NEUTROPENIA MAY BE A PREDICTION MARKER OF THERAPEUTIC EFFECT IN METASTATIC BREAST CANCER PATIENTS TREATED WITH ERIBULIN

PO46 PULMONARY RESECTION FOR LUNG OLIGOMETASTATIC DISEASE IN METASTATIC BREAST CANCER

PO45 SURGICAL RESECTION OF THE PRIMARY TUMOR MAY IMPROVE SURVIVAL IN PATIENTS WITH STAGE IV BREAST CANCER

A multicenter phase II trial of the LH-RH analogue and an aromatase inhibitor combination in premenopausal patients with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: JMTO BC08-01

Clinical Study of Roux Stasis Syndrome after Distal Gastrectomy

Suchergebnisse filtern